Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epclusa for Chronic HCV Post-Lung Transplant
NCT03207399Phase 4Terminated
- Sponsor
- Duke University
- Start
- Sep 2017
- Primary completion
- Mar 2019
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of velpatasvir in hepatitis C virus infection, sponsored by Duke University. Started Sep 2017; status: terminated.
02
Drugs
velpatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT03207399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03207399.